Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
1993-8-10
|
pubmed:abstractText |
Bovine leukaemia virus (BLV) is the aetiological agent of Leukosis enzootica bovis [Viral Oncology (1980), G. Klein (Ed.) Raven Press, New York, pp. 231-238], a widely spread disease in cattle. BLV is reported as the animal model of human T-cell leukaemia virus (HLTV) which is the causative agent of adult T-cell leukaemia and tropical spastic paraparesis. Like the viruses themselves, the two retroviral proteinases (PR) are very closely related [Virology 142 (1985) 357-377]. BLV and HTLV-I PR are reported as putative proteins made of 126 [J. Virol. 57 (1986) 826-832] and 125 [FEBS Lett. 293 (1991) 106-110] amino acids, respectively (long sequences), belonging to the aspartyl proteinase family [Nature 329 (1987) 351-354], with the aid of molecular modelling, we show that BLV and HTLV-I proteinases made of only 116 and 115 amino acids, respectively (short sequences), display three-dimensional structures similar to that observed for other retroviral aspartyl proteinases. The models are based on three-dimensional structures of Rous sarcoma virus (RSV PR) and the human immunodeficiency virus (HIV-1 PR). We used solid phase peptide synthesis to produce the putative proteolytic enzyme of BLV (116 amino acids). In this study, we show that the folded synthetic protease accurately hydrolyzes a decapeptide corresponding to the sequence of the Matrice-Capside (MA/CA) cleavage site of the gag polyprotein. In addition, the proteolytic activity is inhibited by a statine ((4S,3S)-4-amino-3-hydroxyl-6-methylheptanoic acid) containing an analogous sequence.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0014-5793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
12
|
pubmed:volume |
326
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
237-40
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8392000-Amino Acid Sequence,
pubmed-meshheading:8392000-Endopeptidases,
pubmed-meshheading:8392000-Human T-lymphotropic virus 1,
pubmed-meshheading:8392000-Leukemia Virus, Bovine,
pubmed-meshheading:8392000-Models, Molecular,
pubmed-meshheading:8392000-Molecular Sequence Data,
pubmed-meshheading:8392000-Molecular Structure,
pubmed-meshheading:8392000-Protein Folding,
pubmed-meshheading:8392000-Structure-Activity Relationship,
pubmed-meshheading:8392000-Substrate Specificity
|
pubmed:year |
1993
|
pubmed:articleTitle |
Modelling, synthesis and biological activity of a BLV proteinase, made of (only) 116 amino acids.
|
pubmed:affiliation |
Laboratoire de Cristallographie, URA 144 CNRS, Université de Bordeaux I, Talence, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|